Mealey's (May 12, 2023, 12:00 PM EDT) -- WASHINGTON, D.C. — A federal judge in Delaware did not err in declaring obvious four Vanda Pharmaceuticals Inc. patents relating to the use of tasimelteon to treat the sleep-wake disorder known as “non-24,” the Federal Circuit U.S. Court of Appeals said....